RxDoctor Payments Data

Daniel Simon, PA

Physician Assistant · Spokane, WANPI 1639471667

Payments from drug & device makers

$1,675in general payments, 2019–2025

Across 74 payments — averaging $22.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$717
  • Johnson & Johnson$249
  • Takeda Pharmaceuticals U.S.A., Inc.$222
  • Boston Scientific$88
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$78
  • Madrigal Pharmaceuticals$69
  • plus $251 from 10 others

What the payments were for

  • Food & beverage$1,62497%
  • Education$513%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,675 in reported general payments places this provider in the 85th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington

Medicare billing

Part B allowed, 2024
$18,918
Medicare patients
125
Services billed
174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin106$337,121
OcalivaObeticholic Acid17$231,525
VemlidyTenofovir Alafenamide19$33,162
Ursodiol111$11,656
LinzessLinaclotide16$8,307
Entecavir28$6,332
Spironolactone133$1,963
Dexlansoprazole DrDexlansoprazole11$1,762
Azathioprine38$1,370
Octreotide Acetate13$1,217
Lactulose19$984
Amiloride Hcl29$873
Pantoprazole Sodium79$691
Furosemide155$610
ConstuloseLactulose18$501

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$78$337,121106 claims
GileadVemlidy$19$33,16219 claims
AbbVieLinzess$717$8,30716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,741 physician assistant providers in Washington.

Other physician assistant in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →